Extended Data Fig. 7: Low-dose Daunorubicin performs similarly to Low-dose Doxorubicin.
From: Overcoming Wnt–β-catenin dependent anticancer therapy resistance in leukaemia stem cells
From: Overcoming Wnt–β-catenin dependent anticancer therapy resistance in leukaemia stem cells